Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMIS

Authors

Yao Zhu (ORCID: https://orcid.org/0000-0001-7950-6669)
Stephen J. Freedland (ORCID: https://orcid.org/0000-0002-8104-6419)
Dingwei Ye (ORCID: https://orcid.org/0000-0001-7770-9753)
Beihe Wang (ORCID: https://orcid.org/0000-0002-6836-8720)
Xudong Ni (ORCID: https://orcid.org/0009-0005-3131-8964)
Jing Sui (ORCID: https://orcid.org/0000-0001-8223-9872)
Hongkai Wang (ORCID: https://orcid.org/0000-0003-3727-4817)

Institutions

Cedars-Sinai Medical Center (US)
Shanghai Medical College of Fudan University (CN)
Fudan University Shanghai Cancer Center (CN)
Shanghai Cancer Institute (CN)
Durham VA Medical Center (US)

Publication Details

Journal: The Journal of Urology
Published: 2025-03-25
DOI: https://doi.org/10.1097/ju.0000000000004545
Citations: 1
Primary Topic: Prostate Cancer Treatment and Research
Type: article
Field-Weighted Citation Impact: 1.52

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMIS

Yao Zhu, Stephen J. Freedland, Dingwei Ye, Beihe Wang et al.

Mar 25, 2025

1 citations

The Journal of Urology

Prostate Cancer Treatment and Research

1.52

article

Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMIS

Yao Zhu, Stephen J. Freedland, Dingwei Ye, Beihe Wang, Xudong Ni, Jing Sui, Hongkai Wang

March 25, 2025article en

1 citations

Abstract

No abstract available for this paper.

The Journal of UrologyVol. 214(1)

Cedars-Sinai Medical Center (US), Shanghai Medical College of Fudan University (CN), Fudan University Shanghai Cancer Center (CN), Shanghai Cancer Institute (CN), Durham VA Medical Center (US)

Zero hunger

Openalex Percentile: Top 21%

Prostate Cancer Treatment and Research

1.52

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMIS — Yao Zhu, Stephen J. Freedland, et al. · The Journal of Urology (2025) | TGRS Research Map | TGRS